Zealand Pharma A-S News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.09.22	Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) (GlobeNewswire)
19.09.22	Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE Meeting (GlobeNewswire)
07.09.22	Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference (GlobeNewswire)
04.08.22	Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022 (GlobeNewswire)
03.06.22	Zealand Pharma to Participate in Upcoming Investor Conferences (GlobeNewswire)
02.06.22	Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer (GlobeNewswire)
05.05.22	Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022 (GlobeNewswire)
04.04.22	Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
03.03.22	Zealand Pharma Hosts Conference Call on March 10 at 4 pm CET (10am ET) to Present Full Year Results for 2021 (GlobeNewswire)
03.01.22	Zealand Pharma to Participate in H.C. Wainwright BIOCONNECT 2022 Conference (GlobeNewswire)
16.12.21	Zealand Pharma Announces Enrollment of Last Patient Needed for Interim Analysis of EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome (GlobeNewswire)
12.11.21	Zealand Pharma to Participate in Jefferies London Healthcare Conference (GlobeNewswire)
04.11.21	Zealand Pharma Hosts Conference Call on November 11 at 4 pm CET (10 am ET) to Present Third Quarter Results for 2021 (GlobeNewswire)
03.09.21	Zealand Pharma to Participate in Morgan Stanley 19th Annual Global Healthcare Conference (GlobeNewswire)
31.08.21	Zealand Pharma to Participate in Goldman Sachs 11th Annual Biotech Symposium (GlobeNewswire)
19.08.21	Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome (GlobeNewswire)
05.08.21	Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021 (GlobeNewswire)
22.06.21	Zealand Pharma to Participate in LifeSci Nordic Biotech Summit (GlobeNewswire)
03.06.21	Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference (GlobeNewswire)
26.05.21	Zealand Pharma to participate in Jefferies Virtual Healthcare Conference (GlobeNewswire)
05.05.21	Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10 am ET) to Present First Quarter Results for 2021 (GlobeNewswire)
03.05.21	Zealand Pharma announces publication of Phase 3 trial evaluating efficacy and safety of dasiglucagon for treatment of severe hypoglycemia in adult patients with diabetes (GlobeNewswire)
25.03.21	Zealand Pharma to participate in upcoming investor conferences (GlobeNewswire)
04.03.21	Zealand Pharma Virtual R&D Day Materials Now Available with Live Q&A Session on March 5, 2021 (GlobeNewswire)
03.03.21	Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020 (GlobeNewswire)
23.02.21	Zealand Pharma to participate in upcoming investor conferences (GlobeNewswire)
09.02.21	Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference (GlobeNewswire)
04.02.21	Zealand Pharma to Host R&D Day on March 5, 2021 (GlobeNewswire)
11.11.20	Zealand Pharma: (GlobeNewswire)
05.11.20	Zealand Pharma hosts conference call on November 12 at 4 pm CET (10am ET) to present third quarter results for 2020 (GlobeNewswire)
04.09.20	Zealand Pharma builds Global Medical Affairs function with world-renowned experts (GlobeNewswire)
03.09.20	Zealand Pharma to participate in upcoming investor conferences (GlobeNewswire)
06.08.20	Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) to present second quarter results for 2020 (GlobeNewswire)
03.08.20	Zealand Pharma Continues to Build Investor Relations and Communications Function with the Appointment of Mads Kronborg (GlobeNewswire)
06.07.20	Zealand Pharma Expands U.S. Operations, Opens New Boston Office (GlobeNewswire)
14.06.20	Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association (GlobeNewswire)
13.06.20	Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go® in older adults with type 2 diabetes, at the 80th Scientific Sessions of the American Diabetes Associa (GlobeNewswire)
10.06.20	Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process (GlobeNewswire)
01.06.20	Zealand Pharma to attend Jefferies and Goldman Sachs Virtual Healthcare Conferences (GlobeNewswire)
20.04.20	Zealand Pharma hosts conference call on May 14 at 4 pm CEST (10 am EDT) to present first quarter results for 2020 (GlobeNewswire)
31.03.20	Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia (GlobeNewswire)
27.02.20	Zealand Pharma to attend Credit Suisse 2020 Global Healthcare Conference (GlobeNewswire)
26.02.20	Zealand Pharma hosts conference call on March 12 at 4 pm CET (10 am EST) to present full year results for 2019 (GlobeNewswire)
20.02.20	Zealand Pharma to attend 9th Annual SVB Leerink Global Healthcare Conference (GlobeNewswire)
04.12.19	Zealand Pharma initiates second Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism (GlobeNewswire)
28.10.19	Zealand Pharma hosts conference call on November 14 at 4 PM CET (10 AM ET) to present third quarter results for 2019 (GlobeNewswire)
29.08.19	Zealand Pharma to attend Morgan Stanley 17th Annual Global Healthcare Conference (GlobeNewswire)
27.08.19	Zealand Pharma relocates headquarters to accommodate growth (GlobeNewswire)
01.08.19	Zealand Pharma hosts conference call on August 15 at 4 pm CET (10 am EST) to present first half results for 2019 (GlobeNewswire)
26.06.19	Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Zealand Pharma A-S

Aktien Top/Flop

Meistgelesene Nachrichten